speb/financial-data huggingface dataset:
CLPT balance_sheet (annual, 2025-12-31) — Common Stock: 294000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Common Stock: 294000.00
CLPT balance_sheet (annual, 2025-12-31) — Common Stock Equity: 28020000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 28020000.00
CLPT cash_flow (annual, 2025-12-31) — Common Stock Issuance: 3263000.00
CLPT cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
CLPT income_statement (annual, 2025-12-31) — Cost Of Revenue: 14279000.00
CLPT income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 4006000.00
CLPT balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 2786000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 2786000.00
CLPT balance_sheet (annual, 2025-12-31) — Current Assets: 63600000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Current Assets: 63600000.00
CLPT balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 694000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 694000.00
CLPT balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 694000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 694000.00
CLPT balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 1669000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 1669000.00
CLPT balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 1669000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 1669000.00
CLPT balance_sheet (annual, 2025-12-31) — Current Liabilities: 10765000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 10765000.00
CLPT cash_flow (annual, 2025-12-31) — Depreciation: 2069000.00
CLPT cash_flow (quarterly, 2025-12-31) — Depreciation: 683000.00
CLPT cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 2237000.00
CLPT cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 851000.00
CLPT cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 2237000.00
CLPT cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 851000.00
CLPT income_statement (annual, 2025-12-31) — Diluted Average Shares: 28315254.00
CLPT income_statement (annual, 2025-12-31) — Diluted EPS: -0.90
CLPT income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -25540000.00
CLPT income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -7786000.00
CLPT income_statement (annual, 2025-12-31) — EBIT: -23097000.00
CLPT income_statement (quarterly, 2025-12-31) — EBIT: -5866000.00
CLPT income_statement (annual, 2025-12-31) — EBITDA: -20860000.00
CLPT income_statement (quarterly, 2025-12-31) — EBITDA: -5015000.00
CLPT cash_flow (annual, 2025-12-31) — End Cash Position: 46973000.00
CLPT cash_flow (quarterly, 2025-12-31) — End Cash Position: 46973000.00
CLPT cash_flow (annual, 2025-12-31) — Financing Cash Flow: 50179000.00
CLPT cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 19564000.00
CLPT balance_sheet (annual, 2025-12-31) — Finished Goods: 4813000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Finished Goods: 4813000.00
CLPT cash_flow (annual, 2025-12-31) — Free Cash Flow: -24447000.00
CLPT cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -12129000.00
CLPT income_statement (annual, 2025-12-31) — General And Administrative Expense: 16498000.00
CLPT income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 5442000.00
CLPT balance_sheet (annual, 2025-12-31) — Goodwill: 7472000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Goodwill: 7472000.00
CLPT balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 21394000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 21394000.00
CLPT balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 7749000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 7749000.00
CLPT balance_sheet (annual, 2025-12-31) — Gross PPE: 12768000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Gross PPE: 12768000.00
CLPT income_statement (annual, 2025-12-31) — Gross Profit: 22692000.00
CLPT income_statement (quarterly, 2025-12-31) — Gross Profit: 6404000.00
CLPT cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 69000.00
CLPT cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 0.00
CLPT income_statement (annual, 2025-12-31) — Interest Expense: 2388000.00
CLPT income_statement (quarterly, 2025-12-31) — Interest Expense: 1916000.00
CLPT income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 2388000.00
CLPT income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1916000.00
CLPT income_statement (annual, 2025-12-31) — Interest Income: 1213000.00
CLPT income_statement (annual, 2025-12-31) — Interest Income Non Operating: 1213000.00
CLPT cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 908000.00
CLPT cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 418000.00
CLPT balance_sheet (annual, 2025-12-31) — Inventories Adjustments Allowances: -3506000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Inventories Adjustments Allowances: -3506000.00
CLPT balance_sheet (annual, 2025-12-31) — Inventory: 8359000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Inventory: 8359000.00
CLPT balance_sheet (annual, 2025-12-31) — Invested Capital: 77097000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Invested Capital: 77097000.00
CLPT cash_flow (annual, 2025-12-31) — Investing Cash Flow: 615000.00
CLPT cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 1088000.00
CLPT cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 3263000.00
CLPT cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
CLPT cash_flow (annual, 2025-12-31) — Issuance Of Debt: 48086000.00
CLPT cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 19433000.00
CLPT balance_sheet (annual, 2025-12-31) — Leases: 485000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Leases: 485000.00
CLPT balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 8461000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 8461000.00
CLPT balance_sheet (annual, 2025-12-31) — Long Term Debt: 49077000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 49077000.00
CLPT balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 57538000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 57538000.00
CLPT cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 48086000.00
CLPT cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 19433000.00
CLPT cash_flow (annual, 2025-12-31) — Long Term Debt Payments: 0.00
CLPT cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 0.00
CLPT cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 1137000.00
CLPT cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 3263000.00
CLPT cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
CLPT balance_sheet (annual, 2025-12-31) — Net Debt: 3154000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Net Debt: 3154000.00
CLPT income_statement (annual, 2025-12-31) — Net Income: -25540000.00
CLPT income_statement (quarterly, 2025-12-31) — Net Income: -7786000.00
CLPT income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -25540000.00
CLPT income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -7786000.00
CLPT income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -25540000.00
CLPT income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -7786000.00
CLPT income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -25540000.00
CLPT income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -7786000.00
CLPT income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -25540000.00
CLPT income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -7786000.00
CLPT cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -25540000.00
CLPT cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -7786000.00
CLPT income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -25540000.00
CLPT income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -7786000.00
CLPT income_statement (annual, 2025-12-31) — Net Interest Income: -1175000.00
CLPT income_statement (quarterly, 2025-12-31) — Net Interest Income: -703000.00
CLPT cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 48086000.00
CLPT cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 19433000.00
CLPT cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 48086000.00
CLPT cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 19433000.00
CLPT income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -1175000.00
CLPT income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -703000.00
CLPT cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -1856000.00
CLPT cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -195000.00
CLPT balance_sheet (annual, 2025-12-31) — Net PPE: 11051000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Net PPE: 11051000.00
CLPT cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -522000.00
CLPT cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -49000.00
CLPT balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 6626000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 6626000.00
CLPT balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 935000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 935000.00
CLPT balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 581000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 581000.00
CLPT balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 354000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 354000.00
CLPT income_statement (annual, 2025-12-31) — Normalized EBITDA: -20860000.00
CLPT income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -5015000.00
CLPT income_statement (annual, 2025-12-31) — Normalized Income: -25540000.00
CLPT income_statement (quarterly, 2025-12-31) — Normalized Income: -7786000.00
CLPT cash_flow (annual, 2025-12-31) — Operating Cash Flow: -23925000.00
CLPT cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -12080000.00
CLPT income_statement (annual, 2025-12-31) — Operating Income: -24164000.00
CLPT income_statement (quarterly, 2025-12-31) — Operating Income: -7045000.00
CLPT income_statement (annual, 2025-12-31) — Operating Revenue: 36971000.00
CLPT income_statement (quarterly, 2025-12-31) — Operating Revenue: 10410000.00
CLPT balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 29368760.00
CLPT balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 29368760.00
CLPT balance_sheet (annual, 2025-12-31) — Other Current Assets: 2769000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 2769000.00
CLPT balance_sheet (annual, 2025-12-31) — Other Equity Interest: 5641000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 5641000.00
CLPT income_statement (annual, 2025-12-31) — Other Gand A: 16498000.00
CLPT income_statement (quarterly, 2025-12-31) — Other Gand A: 5442000.00
CLPT income_statement (annual, 2025-12-31) — Other Income Expense: -146000.00
CLPT income_statement (quarterly, 2025-12-31) — Other Income Expense: -34000.00
CLPT balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 13922000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 13922000.00
CLPT cash_flow (annual, 2025-12-31) — Other Non Cash Items: 991000.00
CLPT cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 441000.00
CLPT balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 1702000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 1702000.00
CLPT balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 489000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 489000.00
CLPT income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -146000.00
CLPT income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -34000.00
CLPT balance_sheet (annual, 2025-12-31) — Other Properties: 12283000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Other Properties: 12283000.00
CLPT balance_sheet (annual, 2025-12-31) — Payables: 1256000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Payables: 1256000.00
CLPT balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 4042000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 4042000.00
CLPT balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4360000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4360000.00
CLPT balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CLPT balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CLPT income_statement (annual, 2025-12-31) — Pretax Income: -25485000.00
CLPT income_statement (quarterly, 2025-12-31) — Pretax Income: -7782000.00
CLPT cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 686000.00
CLPT cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 326000.00
CLPT balance_sheet (annual, 2025-12-31) — Properties: 0.00
CLPT balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CLPT cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 21000.00
CLPT cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: -196000.00
CLPT cash_flow (annual, 2025-12-31) — Purchase Of PPE: -522000.00
CLPT cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -49000.00
CLPT balance_sheet (annual, 2025-12-31) — Raw Materials: 7052000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Raw Materials: 7052000.00
CLPT balance_sheet (annual, 2025-12-31) — Receivables: 6549000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Receivables: 6549000.00
CLPT income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 14279000.00
CLPT income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 4006000.00
CLPT income_statement (annual, 2025-12-31) — Reconciled Depreciation: 2237000.00
CLPT income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 851000.00
CLPT cash_flow (annual, 2025-12-31) — Repayment Of Debt: 0.00
CLPT cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
CLPT income_statement (annual, 2025-12-31) — Research And Development: 13897000.00
CLPT income_statement (quarterly, 2025-12-31) — Research And Development: 3237000.00
CLPT balance_sheet (annual, 2025-12-31) — Retained Earnings: -216910000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -216910000.00
CLPT cash_flow (annual, 2025-12-31) — Sale Of Business: 1137000.00
CLPT income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 16461000.00
CLPT income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 4770000.00
CLPT income_statement (annual, 2025-12-31) — Selling General And Administration: 32959000.00
CLPT income_statement (quarterly, 2025-12-31) — Selling General And Administration: 10212000.00
CLPT balance_sheet (annual, 2025-12-31) — Share Issued: 29368760.00
CLPT balance_sheet (quarterly, 2025-12-31) — Share Issued: 29368760.00
CLPT cash_flow (annual, 2025-12-31) — Stock Based Compensation: 8180000.00
CLPT cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1981000.00
CLPT balance_sheet (annual, 2025-12-31) — Stockholders Equity: 28020000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 28020000.00
CLPT balance_sheet (annual, 2025-12-31) — Tangible Book Value: 6626000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 6626000.00
CLPT income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CLPT income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CLPT income_statement (annual, 2025-12-31) — Tax Provision: 55000.00
CLPT income_statement (quarterly, 2025-12-31) — Tax Provision: 4000.00
CLPT income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
CLPT income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
CLPT balance_sheet (annual, 2025-12-31) — Total Assets: 97747000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Total Assets: 97747000.00
CLPT balance_sheet (annual, 2025-12-31) — Total Capitalization: 77097000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 77097000.00
CLPT balance_sheet (annual, 2025-12-31) — Total Debt: 58232000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Total Debt: 58232000.00
CLPT balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 28020000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 28020000.00
CLPT income_statement (annual, 2025-12-31) — Total Expenses: 61135000.00
CLPT income_statement (quarterly, 2025-12-31) — Total Expenses: 17455000.00
CLPT balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 69727000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 69727000.00
CLPT balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 34147000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 34147000.00
CLPT balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 58962000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 58962000.00
CLPT income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -24164000.00
CLPT income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -7045000.00
CLPT balance_sheet (annual, 2025-12-31) — Working Capital: 52835000.00
CLPT balance_sheet (quarterly, 2025-12-31) — Working Capital: 52835000.00
CLPT income_statement (quarterly, 2026-03-31) — +Operating Expense: 16234000.00
CLPT income_statement (quarterly, 2026-03-31) — +Total Revenue: 12128000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 2330000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 8662000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 239468000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1100000.00
CLPT cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 504000.00
CLPT cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 504000.00
CLPT income_statement (quarterly, 2026-03-31) — Basic Average Shares: 29546889.00
CLPT income_statement (quarterly, 2026-03-31) — Basic EPS: -0.32
CLPT cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 46973000.00
CLPT cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -645000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 13944000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Capital Stock: 300000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 35593000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 35593000.00
CLPT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -1845000.00
CLPT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -645000.00
CLPT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -7967000.00
CLPT cash_flow (quarterly, 2026-03-31) — Change In Inventory: -125000.00
CLPT cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -71000.00
CLPT cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -391000.00
CLPT cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 172000.00
CLPT cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -437000.00
CLPT cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 653000.00
CLPT cash_flow (quarterly, 2026-03-31) — Change In Receivables: -2019000.00
CLPT cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -2218000.00
CLPT cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -2019000.00
CLPT cash_flow (quarterly, 2026-03-31) — Changes In Cash: -10457000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Common Stock: 300000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 18841000.00
CLPT income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 4372000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 2125000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Current Assets: 54877000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 234000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 234000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 1814000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 1814000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 9480000.00
CLPT cash_flow (quarterly, 2026-03-31) — Depreciation: 609000.00
CLPT cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1113000.00
CLPT cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 1113000.00
CLPT income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 29546889.00
CLPT income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.32
CLPT income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -9552000.00
CLPT income_statement (quarterly, 2026-03-31) — EBIT: -8162000.00
CLPT income_statement (quarterly, 2026-03-31) — EBITDA: -7049000.00
CLPT cash_flow (quarterly, 2026-03-31) — End Cash Position: 36516000.00
CLPT cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -1845000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Finished Goods: 5159000.00
CLPT cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -8612000.00
CLPT income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 4997000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Goodwill: 7472000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 20891000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 9762000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Gross PPE: 16002000.00
CLPT income_statement (quarterly, 2026-03-31) — Gross Profit: 7756000.00
CLPT cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 0.00
CLPT income_statement (quarterly, 2026-03-31) — Interest Expense: 1382000.00
CLPT income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1382000.00
CLPT income_statement (quarterly, 2026-03-31) — Interest Income: 351000.00
CLPT income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 351000.00
CLPT cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 525000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Inventories Adjustments Allowances: -3308000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Inventory: 8573000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Invested Capital: 68485000.00
CLPT cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -645000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 13710000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 49644000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 63354000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Net Debt: 14051000.00
CLPT income_statement (quarterly, 2026-03-31) — Net Income: -9552000.00
CLPT income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -9552000.00
CLPT income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -9552000.00
CLPT income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -9552000.00
CLPT income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -9552000.00
CLPT cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -9552000.00
CLPT income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -9552000.00
CLPT income_statement (quarterly, 2026-03-31) — Net Interest Income: -1031000.00
CLPT income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1031000.00
CLPT cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -1993000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Net PPE: 16002000.00
CLPT cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -645000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -2050000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 962000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 608000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 354000.00
CLPT income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -7049000.00
CLPT income_statement (quarterly, 2026-03-31) — Normalized Income: -9552000.00
CLPT cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -7967000.00
CLPT income_statement (quarterly, 2026-03-31) — Operating Income: -8478000.00
CLPT income_statement (quarterly, 2026-03-31) — Operating Revenue: 12128000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 29986639.00
CLPT balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 2049000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 5535000.00
CLPT income_statement (quarterly, 2026-03-31) — Other Gand A: 4997000.00
CLPT income_statement (quarterly, 2026-03-31) — Other Income Expense: -35000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 13419000.00
CLPT cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 567000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1646000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 779000.00
CLPT income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -35000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Other Properties: 16002000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Payables: 2330000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 4455000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2977000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CLPT income_statement (quarterly, 2026-03-31) — Pretax Income: -9544000.00
CLPT cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 148000.00
CLPT cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: -95000.00
CLPT cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -645000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Raw Materials: 6722000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Receivables: 8662000.00
CLPT income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 4372000.00
CLPT income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1113000.00
CLPT income_statement (quarterly, 2026-03-31) — Research And Development: 4522000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -226462000.00
CLPT income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 6715000.00
CLPT income_statement (quarterly, 2026-03-31) — Selling General And Administration: 11712000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Share Issued: 29986639.00
CLPT cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2218000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 18841000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -2050000.00
CLPT income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CLPT income_statement (quarterly, 2026-03-31) — Tax Provision: 8000.00
CLPT income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CLPT balance_sheet (quarterly, 2026-03-31) — Total Assets: 93416000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 68485000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Total Debt: 63588000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 18841000.00
CLPT income_statement (quarterly, 2026-03-31) — Total Expenses: 20606000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 74575000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 38539000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 65095000.00
CLPT income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -8478000.00
CLPT balance_sheet (quarterly, 2026-03-31) — Working Capital: 45397000.00
CLRB balance_sheet (annual, 2021-12-31) — Buildings And Improvements: 204644.00
CLRB cash_flow (annual, 2021-12-31) — Common Stock Issuance: 34873.00
CLRB cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 2937.00
CLRB cash_flow (annual, 2021-12-31) — Interest Paid Supplemental Data: 0.00
CLRB cash_flow (annual, 2021-12-31) — Issuance Of Debt: 0.00
CLRB cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
CLRB cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 34873.00
CLRB cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: 0.00
CLRB cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 0.00
CLRB income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: 6634.00
CLRB balance_sheet (annual, 2021-12-31) — Prepaid Assets: 867485.00
CLRB income_statement (annual, 2021-12-31) — Special Income Charges: 0.00
CLRB income_statement (annual, 2022-12-31) — +Operating Expense: 28813773.00
CLRB income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
CLRB balance_sheet (annual, 2022-12-31) — Accounts Payable: 2558000.00
CLRB balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -692534.00
CLRB balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 168143557.00
CLRB income_statement (annual, 2022-12-31) — Basic Average Shares: 235188.00
CLRB income_statement (annual, 2022-12-31) — Basic EPS: -121.50
CLRB cash_flow (annual, 2022-12-31) — Beginning Cash Position: 35703975.00
CLRB balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 560334.00
CLRB cash_flow (annual, 2022-12-31) — Capital Expenditure: -225971.00
CLRB balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 603828.00
CLRB balance_sheet (annual, 2022-12-31) — Capital Stock: 94.00
CLRB balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 19866358.00
CLRB balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 19866358.00
CLRB cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 9610655.00
CLRB cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -225971.00
CLRB cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -25222301.00
CLRB cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -144035.00
CLRB cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 1623529.00
CLRB cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 204242.00
CLRB cash_flow (annual, 2022-12-31) — Change In Working Capital: 1683736.00
CLRB cash_flow (annual, 2022-12-31) — Changes In Cash: -15837617.00
CLRB balance_sheet (annual, 2022-12-31) — Common Stock: 94.00
CLRB balance_sheet (annual, 2022-12-31) — Common Stock Equity: 8153244.00
CLRB cash_flow (annual, 2022-12-31) — Common Stock Issuance: 9610655.00
CLRB balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 2004000.00
CLRB balance_sheet (annual, 2022-12-31) — Current Assets: 20529601.00
CLRB balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 50847.00
CLRB balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 50847.00
CLRB balance_sheet (annual, 2022-12-31) — Current Liabilities: 11501542.00
CLRB cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 148435.00
CLRB cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 148435.00
CLRB income_statement (annual, 2022-12-31) — Diluted Average Shares: 235188.00
CLRB income_statement (annual, 2022-12-31) — Diluted EPS: -121.50
CLRB income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -31792618.00
CLRB income_statement (annual, 2022-12-31) — EBIT: -28813773.00
CLRB income_statement (annual, 2022-12-31) — EBITDA: -28665338.00
CLRB cash_flow (annual, 2022-12-31) — End Cash Position: 19866358.00
CLRB cash_flow (annual, 2022-12-31) — Financing Cash Flow: 9610655.00
CLRB cash_flow (annual, 2022-12-31) — Free Cash Flow: -25448272.00
CLRB cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 3386.00
CLRB income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 3633241.00
CLRB income_statement (annual, 2022-12-31) — General And Administrative Expense: 10548062.00
CLRB balance_sheet (annual, 2022-12-31) — Gross PPE: 1671509.00
CLRB income_statement (annual, 2022-12-31) — Interest Income: 152519.00
CLRB income_statement (annual, 2022-12-31) — Interest Income Non Operating: 152519.00
CLRB balance_sheet (annual, 2022-12-31) — Invested Capital: 8153244.00
CLRB cash_flow (annual, 2022-12-31) — Investing Cash Flow: -225971.00
CLRB cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 9610655.00
CLRB balance_sheet (annual, 2022-12-31) — Leases: 309897.00
CLRB balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 552981.00
CLRB balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 552981.00
CLRB balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 801278.00
CLRB cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 9610655.00
CLRB income_statement (annual, 2022-12-31) — Net Income: -31792618.00
CLRB income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -31792618.00
CLRB income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -31792618.00
CLRB income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -31792618.00
CLRB income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -31792618.00
CLRB cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -28601254.00
CLRB income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -31792618.00
CLRB income_statement (annual, 2022-12-31) — Net Interest Income: 152519.00
CLRB income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 152519.00
CLRB balance_sheet (annual, 2022-12-31) — Net PPE: 978975.00
CLRB cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -225971.00
CLRB cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 9610655.00
CLRB balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 8153244.00
CLRB income_statement (annual, 2022-12-31) — Normalized EBITDA: -32298579.00
CLRB income_statement (annual, 2022-12-31) — Normalized Income: -35419319.17
CLRB cash_flow (annual, 2022-12-31) — Operating Cash Flow: -25222301.00
CLRB cash_flow (annual, 2022-12-31) — Operating Gains Losses: 3386.00
CLRB income_statement (annual, 2022-12-31) — Operating Income: -28813773.00
CLRB income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
CLRB balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 312842.00
CLRB balance_sheet (annual, 2022-12-31) — Other Current Assets: 663243.00
CLRB balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 5972695.00
CLRB income_statement (annual, 2022-12-31) — Other Gand A: 10548062.00
CLRB income_statement (annual, 2022-12-31) — Other Income Expense: -3191364.00
CLRB cash_flow (annual, 2022-12-31) — Other Non Cash Items: 90432.00
CLRB balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 81214.00
CLRB income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -6824605.00
CLRB balance_sheet (annual, 2022-12-31) — Other Properties: 560334.00
CLRB balance_sheet (annual, 2022-12-31) — Payables: 2558000.00
CLRB balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 4562000.00
CLRB balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 916000.00
CLRB balance_sheet (annual, 2022-12-31) — Preferred Securities Outside Stock Equity: 1382023.00
CLRB balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 204.00
CLRB balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CLRB balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 1382023.00
CLRB cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 9610655.00
CLRB income_statement (annual, 2022-12-31) — Pretax Income: -31852618.00
CLRB cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
CLRB balance_sheet (annual, 2022-12-31) — Properties: 0.00
CLRB cash_flow (annual, 2022-12-31) — Purchase Of PPE: -225971.00
CLRB income_statement (annual, 2022-12-31) — Reconciled Depreciation: 148435.00
CLRB income_statement (annual, 2022-12-31) — Research And Development: 18265711.00
CLRB balance_sheet (annual, 2022-12-31) — Retained Earnings: -159990407.00
CLRB income_statement (annual, 2022-12-31) — Selling General And Administration: 10548062.00
CLRB balance_sheet (annual, 2022-12-31) — Share Issued: 312842.00
CLRB cash_flow (annual, 2022-12-31) — Stock Based Compensation: 1452964.00
CLRB balance_sheet (annual, 2022-12-31) — Stockholders Equity: 8153244.00
CLRB balance_sheet (annual, 2022-12-31) — Tangible Book Value: 8153244.00
CLRB income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 6539.83
CLRB income_statement (annual, 2022-12-31) — Tax Provision: -60000.00
CLRB income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
CLRB balance_sheet (annual, 2022-12-31) — Total Assets: 21589790.00
CLRB balance_sheet (annual, 2022-12-31) — Total Capitalization: 8153244.00
CLRB balance_sheet (annual, 2022-12-31) — Total Debt: 603828.00
CLRB balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 8153244.00
CLRB income_statement (annual, 2022-12-31) — Total Expenses: 28813773.00
CLRB balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 13436546.00
CLRB balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1060189.00
CLRB balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1935004.00
CLRB income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -28813773.00
CLRB income_statement (annual, 2022-12-31) — Total Unusual Items: 3633241.00
CLRB income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 3633241.00
CLRB balance_sheet (annual, 2022-12-31) — Working Capital: 9028059.00
CLRB income_statement (annual, 2023-12-31) — +Operating Expense: 38960643.00
CLRB income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
CLRB balance_sheet (annual, 2023-12-31) — Accounts Payable: 5620000.00
CLRB balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -885000.00
CLRB balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 182924210.00
CLRB income_statement (annual, 2023-12-31) — Basic Average Shares: 407385.00
CLRB income_statement (annual, 2023-12-31) — Basic EPS: -105.00
CLRB cash_flow (annual, 2023-12-31) — Beginning Cash Position: 19866358.00
CLRB cash_flow (annual, 2023-12-31) — Capital Expenditure: -864038.00
CLRB balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 552982.00
CLRB balance_sheet (annual, 2023-12-31) — Capital Stock: 4677839.00
CLRB balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 9564988.00
CLRB balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 9564988.00
CLRB cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 22939642.00
CLRB cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -864038.00
CLRB cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -32376974.00
CLRB cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -50846.00
CLRB cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 3700202.00
CLRB cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -173548.00
CLRB cash_flow (annual, 2023-12-31) — Change In Working Capital: 3475808.00
CLRB cash_flow (annual, 2023-12-31) — Changes In Cash: -10301370.00
CLRB balance_sheet (annual, 2023-12-31) — Common Stock: 207.00
CLRB balance_sheet (annual, 2023-12-31) — Common Stock Equity: -19836600.00
CLRB balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 1490000.00
CLRB balance_sheet (annual, 2023-12-31) — Current Assets: 10453213.00
CLRB balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 58979.00
CLRB balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 58979.00
CLRB balance_sheet (annual, 2023-12-31) — Current Liabilities: 25358522.00
CLRB cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 192375.00
CLRB cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 192375.00
CLRB income_statement (annual, 2023-12-31) — Diluted Average Shares: 407385.00
CLRB income_statement (annual, 2023-12-31) — Diluted EPS: -105.00
CLRB income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -42770610.00
CLRB income_statement (annual, 2023-12-31) — EBIT: -38960643.00
CLRB income_statement (annual, 2023-12-31) — EBITDA: -38768268.00
CLRB cash_flow (annual, 2023-12-31) — End Cash Position: 9564988.00
CLRB cash_flow (annual, 2023-12-31) — Financing Cash Flow: 22939642.00
CLRB cash_flow (annual, 2023-12-31) — Free Cash Flow: -33241012.00
CLRB cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 4257114.00
CLRB cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
CLRB income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -3787114.00
CLRB income_statement (annual, 2023-12-31) — General And Administrative Expense: 11694367.00
CLRB balance_sheet (annual, 2023-12-31) — Gross PPE: 2477283.00
CLRB income_statement (annual, 2023-12-31) — Interest Income: 387147.00
CLRB income_statement (annual, 2023-12-31) — Interest Income Non Operating: 387147.00
CLRB balance_sheet (annual, 2023-12-31) — Invested Capital: -19836600.00
CLRB cash_flow (annual, 2023-12-31) — Investing Cash Flow: -864038.00
CLRB cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 22150000.00
CLRB balance_sheet (annual, 2023-12-31) — Leases: 310000.00
CLRB balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 494003.00
CLRB balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 494003.00
CLRB balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1665000.00
CLRB income_statement (annual, 2023-12-31) — Net Income: -42770610.00
CLRB income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -42770610.00
CLRB income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -42770610.00
CLRB income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -42770610.00
CLRB income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -42770610.00
CLRB cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -42770610.00
CLRB income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -42770610.00
CLRB income_statement (annual, 2023-12-31) — Net Interest Income: 387147.00
CLRB income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 387147.00
CLRB balance_sheet (annual, 2023-12-31) — Net PPE: 1592283.00
CLRB cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -864038.00
CLRB cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 22150000.00
CLRB balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -15158968.00
CLRB income_statement (annual, 2023-12-31) — Normalized EBITDA: -34981154.00
CLRB income_statement (annual, 2023-12-31) — Normalized Income: -38988797.96
CLRB cash_flow (annual, 2023-12-31) — Operating Cash Flow: -32376974.00
CLRB cash_flow (annual, 2023-12-31) — Operating Gains Losses: 4257114.00
CLRB income_statement (annual, 2023-12-31) — Operating Income: -38960643.00
CLRB income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
CLRB balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 691470.00
CLRB balance_sheet (annual, 2023-12-31) — Other Current Assets: 888225.00
CLRB balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 16120543.00
CLRB income_statement (annual, 2023-12-31) — Other Gand A: 11694367.00
CLRB income_statement (annual, 2023-12-31) — Other Income Expense: -4257114.00
CLRB cash_flow (annual, 2023-12-31) — Other Non Cash Items: 58051.00
CLRB balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 29780.00
CLRB income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -470000.00
CLRB balance_sheet (annual, 2023-12-31) — Other Properties: 502283.00
CLRB balance_sheet (annual, 2023-12-31) — Payables: 5620000.00
CLRB balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 7110000.00
CLRB balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2069000.00
CLRB balance_sheet (annual, 2023-12-31) — Preferred Securities Outside Stock Equity: 1382023.00
CLRB balance_sheet (annual, 2023-12-31) — Preferred Stock: 4677632.00
CLRB balance_sheet (annual, 2023-12-31) — Preferred Stock Equity: 4677632.00
CLRB cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 22150000.00
CLRB income_statement (annual, 2023-12-31) — Pretax Income: -42830610.00
CLRB cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 789642.00
CLRB balance_sheet (annual, 2023-12-31) — Properties: 0.00
CLRB cash_flow (annual, 2023-12-31) — Purchase Of PPE: -864038.00
CLRB income_statement (annual, 2023-12-31) — Reconciled Depreciation: 192375.00
CLRB income_statement (annual, 2023-12-31) — Research And Development: 27266276.00
CLRB balance_sheet (annual, 2023-12-31) — Retained Earnings: -202761017.00
CLRB income_statement (annual, 2023-12-31) — Selling General And Administration: 11694367.00
CLRB balance_sheet (annual, 2023-12-31) — Share Issued: 691470.00
CLRB cash_flow (annual, 2023-12-31) — Stock Based Compensation: 2410288.00
CLRB balance_sheet (annual, 2023-12-31) — Stockholders Equity: -15158968.00
CLRB balance_sheet (annual, 2023-12-31) — Tangible Book Value: -19836600.00
CLRB income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -5301.96
CLRB income_statement (annual, 2023-12-31) — Tax Provision: -60000.00
CLRB income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
CLRB balance_sheet (annual, 2023-12-31) — Total Assets: 12075580.00
CLRB balance_sheet (annual, 2023-12-31) — Total Capitalization: -15158968.00
CLRB balance_sheet (annual, 2023-12-31) — Total Debt: 552982.00
CLRB balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -15158968.00
CLRB income_statement (annual, 2023-12-31) — Total Expenses: 38960643.00
CLRB balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 27234548.00
CLRB balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1622063.00
CLRB balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1876026.00
CLRB income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -38960643.00
CLRB income_statement (annual, 2023-12-31) — Total Unusual Items: -3787114.00
CLRB income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -3787114.00
CLRB balance_sheet (annual, 2023-12-31) — Working Capital: -14905309.00
CLRB income_statement (quarterly, 2024-09-30) — Average Dilution Earnings: -1428355.00
CLRB income_statement (quarterly, 2024-09-30) — Basic Average Shares: 1311197.00